Fortress Biotech, Inc.FBIONASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P14
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2024-3.57%
2023-19.95%
202230.88%
202141.98%
202010.03%
20194.16%
2018-26.90%
2017121.83%
201652.50%
2015107.28%